The Lehigh Valley plant will be Indianapolis-based Lilly’s first manufacturing facility in Pennsylvania. Construction is expected to begin this year and be completed by 2031.

Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the second quarter.

On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, rounding out the quartet of plants it promised during its “Lilly in America” investment announcement last year.

The state is providing $100 million in support for the project, which is expected to create 2,000 temporary construction jobs and 850 permanent jobs.

By Christy Santhosh Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the Massachusetts-based biotech said on Thursday.

U.S. drugmaker Eli Lilly and Company signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to develop and commercialize treatments for hearing loss using the biotech’s gene-editing platform.

ALLENTOWN - In a big win for Pennsylvania and the Lehigh Valley, Eli Lilly & Co. has announced plans to build a $3.5 billion drug production plant in Lehigh County. Gov. Josh Shapiro says Lilly’s commitment is the largest private-sector life sciences investment in Pennsylvania’s history.

Both companies may succeed in this industry.

Eli Lilly & Co. plans to build a $3.5 billion pharmaceutical plant in the Lehigh Valley to expand manufacturing capacity for next-generation weight-loss medicines, the Indiana company announced Friday in Allentown.

Evangeline Lilly, who has been navigating a traumatic brain injury following a concussion, opened up about her recovery efforts on social media.